# Healthcap IX Advisor AB: portfolio, investments and team > Healthcap IX Advisor AB is an investment firm based in Sweden. 24 investments on record, latest Dec 2012. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/healthcap-ix-advisor-ab (Millionrounds; every figure on the page links to its filing or article) Sweden · [Investor](https://millionrounds.com/investors) # Healthcap IX Advisor AB Last cheque observed Dec 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Investment firm Series C Series A Venture Cheques on record **0%** of best year **0** **cheques in 12 months**, 24 on record Since the last cheque **5047** days **00** hrs **00** min **00** sec Median round **$20M** Rounds led **0 of 24** Sole investor **1 rounds** Exits **4 from the portfolio** Mostly in **United States, 46%** Pitch Healthcap IX Advisor AB ## Healthcap IX Advisor AB highlights - 01 24 rounds on record - 02 Mostly Series C and Series A: 52% of its rounds - 03 Sole investor in 1 rounds, median $5.5M - 04 4 exits from the portfolio ## What they do > SEC Form ADV: exempt reporting adviser From their own website - **Type:** Investment firm (from a list, unverified) - **Cheque size:** Not stated - **Based in:** Stockholm, Sweden - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **24 appearances** - **2012** 2 rounds - **Dec** **[Ultragenyx Pharmaceutical](https://millionrounds.com/company/ultragenyx-pharmaceutical)** Growth · US · globenewswire.com **$75M** With 6 others - **Jun** **[BONESUPPORT](https://millionrounds.com/company/bonesupport)** SE · finsmes.com **$10.0M** With 2 others - **2011** 4 rounds - **Jul** **[SpineVision](https://millionrounds.com/company/spinevision)** Venture · FR · finsmes.com **$5.0M** With 3 others - **Jun** **[BONESUPPORT](https://millionrounds.com/company/bonesupport)** Venture · SE · finsmes.com **$19M** With 1 other - **Jun** **[Ultragenyx Pharmaceutical](https://millionrounds.com/company/ultragenyx-pharmaceutical)** Series A · US · finsmes.com **$45M** With 4 others - **Jan** **[Nexstim](https://millionrounds.com/company/nexstim)** Venture · FI · tmcnet.com **$15M** With 5 others - **2010** 6 rounds - **Sept** **[Cardoz](https://millionrounds.com/company/cardoz)** Series A · SE · finsmes.com **$18M** With 3 others - **Jul** **[Cerenis Therapeutics](https://millionrounds.com/company/cerenis-therapeutics)** Series C · FR · cerenis.com **$52M** With 6 others - **Jun** **[FerroKin Biosciences](https://millionrounds.com/company/ferrokin-biosciences)** Series B · US · fiercebiotech.com **$12M** With 4 others - **Apr** **[Oncos Therapeutics](https://millionrounds.com/company/oncos-therapeutics)** Series C · FI · onbiovc.com **$5.5M** Sole investor - **Mar** **[Immune Targeting Systems](https://millionrounds.com/company/immune-targeting-systems)** Series A · GB · onbiovc.com **$13M** With 3 others - **Mar** **[Pulmonx](https://millionrounds.com/company/pulmonx)** Series C · US · onbiovc.com **$32M** With 6 others - **2009** 2 rounds - **Sept** **[BeneChill](https://millionrounds.com/company/benechill)** Series C · US · onbiovc.com **$14M** With 2 others - **Jun** **[Lumavita](https://millionrounds.com/company/lumavita)** Series A · CH · onbiovc.com **$5.5M** With 1 other - **2007** 2 rounds - **Oct** **[Tengion](https://millionrounds.com/company/tengion)** Series C · US · tengion.com **$33M** With 8 others - **Jun** **[OxThera](https://millionrounds.com/company/oxthera)** SE · oxthera.com **$22M** With 3 others - **2006** 3 rounds - **Nov** **[BONESUPPORT](https://millionrounds.com/company/bonesupport)** SE · bulletin.sciencebusiness.net **$20M** With 5 others - **Sept** **[Resistentia Pharmaceuticals](https://millionrounds.com/company/resistentia-pharmaceuticals)** Series C · SE **$14M** With 4 others - **Jun** **[Tengion](https://millionrounds.com/company/tengion)** Series B · US · tengion.com **$50M** With 6 others - **2005** 4 rounds - **Nov** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Growth · US · ptct.client.shareholder.com **$27M** With 10 others - **Aug** **[Tengion](https://millionrounds.com/company/tengion)** Series A · US · phx.corporate-ir.net **$39M** With 3 others - **Jul** **[OxThera](https://millionrounds.com/company/oxthera)** Venture · SE · oxthera.com **$21M** With 1 other - **Feb** **[Five Prime Therapeutics](https://millionrounds.com/company/five-prime-therapeutics)** Venture · US · fiveprime.com **$45M** With 9 others - **2004** 1 round - **Jun** **[ChemoCentryx](https://millionrounds.com/company/chemocentryx)** Series B · US · chemocentryx.com **$33M** With 4 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$3.4M** gross assets of its funds Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** Healthcap IX Advisor AB - **SEC number:** CRD 330436 ## Exits from the portfolio Companies it backed that were later bought or listed **4 in all** **[Immune Targeting Systems](https://millionrounds.com/company/immune-targeting-systems)** Bought by Vaxin **Undisclosed** Feb 2015 **[Five Prime Therapeutics](https://millionrounds.com/company/five-prime-therapeutics)** Listed **Undisclosed** Jul 2013 **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Listed **$125M** Jun 2013 **[Tengion](https://millionrounds.com/company/tengion)** Listed **Undisclosed** Apr 2010 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series C Series A Venture Median round joined **$20M** the round, not its cheque Alone, median **$5.5M** Led 0 of 24 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Dec 2012 - **Exits:** 4 from the portfolio Rounds by stage said on their site - Series C *6* - Series A *5* - Venture *5* - Series B *3* - Growth *2* Cheques by year Led Joined 2004 2012 Often in the room with - [Industrifonden](https://millionrounds.com/fund/industrifonden) 5 - [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) 3 - [L Capital Partners](https://millionrounds.com/fund/l-capital-partners) 3 - [Oak Investment Partners](https://millionrounds.com/fund/oak-investment-partners) 3 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 2 - [Bain Capital](https://millionrounds.com/fund/bain-capital) 2 **Pitching Healthcap IX Advisor AB?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Healthcap IX Advisor AB. A count of rooms they were both in, not a relationship either has claimed. [**Industrifonden** VC firm **5** rounds together](https://millionrounds.com/fund/industrifonden)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **3** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**L Capital Partners** VC firm **3** rounds together](https://millionrounds.com/fund/l-capital-partners)[**Oak Investment Partners** Private equity **3** rounds together](https://millionrounds.com/fund/oak-investment-partners)[**Alta Partners** VC firm **2** rounds together](https://millionrounds.com/fund/alta-partners)[**Bain Capital** Private equity **2** rounds together](https://millionrounds.com/fund/bain-capital)[**F-Prime Capital** VC firm **2** rounds together](https://millionrounds.com/fund/f-prime)[**Fidelity Biosciences** Investment firm **2** rounds together](https://millionrounds.com/fund/fidelity-biosciences)[**HBM BioVentures** Growth equity **2** rounds together](https://millionrounds.com/fund/hbm-bioventures)[**InnovationsKapital** Investment firm **2** rounds together](https://millionrounds.com/fund/innovationskapital)[**Kleiner Perkins Caufield & Byers** VC firm **2** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**Lundbeckfond Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/lundbeckfond-ventures) ## Quick answers about Healthcap IX Advisor AB ### What does Healthcap IX Advisor AB invest in? Healthcap IX Advisor AB invests most often at Series C and Series A (52% of the rounds on record). ### How active is Healthcap IX Advisor AB? 24 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2012. ### How big are Healthcap IX Advisor AB's cheques? The median round it joins is $20M. ### Does Healthcap IX Advisor AB lead rounds? Rarely, if at all: none of its 24 investments on record names it as the lead. ### Where does Healthcap IX Advisor AB invest? Most of the companies it backs are in the United States (46%), Sweden (29%) and France (8%). ### Is Healthcap IX Advisor AB investing now? No investments in the last 12 months; the latest was in Dec 2012. ### Who does Healthcap IX Advisor AB invest alongside? Most often Industrifonden (5 rounds together), Johnson & Johnson Development Corporation (JJDC) (3 rounds together) and L Capital Partners (3 rounds together). ### What kind of investor is Healthcap IX Advisor AB? Healthcap IX Advisor AB is an investment firm based in Stockholm, Sweden. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=healthcap-ix-advisor-ab) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=healthcap-ix-advisor-ab)